A Study to Evaluate the Efficacy and Safety of AK111 in Subjects With Active Ankylosing Spondylitis
NCT05467995
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
125
Enrollment
INDUSTRY
Sponsor class
Conditions
Ankylosing Spondylitis
Interventions
BIOLOGICAL:
AK111
BIOLOGICAL:
Placebo
Sponsor
Akeso